Seagen (Canada)

Seagen (Canada)

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Seagen (Canada), Canada, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

76%


Total
Publications

87


Total Open
Publications

66


Total
Citations

6.3K


Open Access
Percentage

76%


Total
Publications

87


Total Open
Publications

66


Total
Citations

6.3K

Wikipedia

Website

download

Breakdown

28% 31% 17% 24%

Publisher Open

28%

Both

31%

Other Platform Open

17%

Closed

24%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

17%OA Journal

OA Journal 17%

9

Hybrid 16%

8

No Guarantees 67%

34

Other Platform Open

Domain 88%

37

Institution 21%

9

Preprint 7%

3

Other Internet 5%

2

Public 2%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
36
Europe PMC
Domain
24
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
4
Research Square
Preprint
3
University of Michigan - Deep Blue
Institution
2
Harvard University - Digital Access to Scholarship at Harvard (DASH)
Institution
2
University of Toronto - TSpace
Institution
1
University of Szeged - SZTE Publicatio Repozitórium - SZTE - Repository of Publications
Institution
1
University of Debrecen - University of Debrecen Electronic Archive
Institution
1
University of California - eScholarship University of California
Institution
1
1 / 2

Data updated 13 February 2025

Share

Share

Share